Overall survival curves of patients with AML, according to different nm23-H1 levels.

The 102 patients with AML were divided into 2 groups with different nm23-H1 levels over the upper limit in control plasma (6.13 + 2SD = 14.39 ng/mL). (A) 14.39 ng/mL (< 14.39, n = 3 versus ≥ 14.39, n = 99). (B) 30 ng/mL (< 30, n = 17 versus ≥ 30, n = 85). (C) 50 ng/mL (< 50, n = 48 versus ≥ 50, n = 54).